4.7 Review

Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Sepsis and antibiotics: When should we deploy a parachute?

Sharon Einav et al.

Summary: Guidelines recommend early administration of antimicrobial therapy in sepsis and septic shock, based on observational studies suggesting improved outcomes. However, front-line physicians face pressure to quickly decide on antibiotic use in uncertain sepsis cases. Overuse of antibiotics contributes to the emergence of multidrug-resistant bacteria, and this article discusses the situation of physicians criticized for unnecessary or delayed antibiotic use and offers options to assist bedside decision-making.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Review Biochemistry & Molecular Biology

MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets

Wanying Zhang et al.

Summary: Sepsis is a life-threatening condition resulting from an uncontrolled host response to infection. Myeloid-derived suppressor cells (MDSCs), which consist of pathologically activated neutrophils and monocytes, play an important role in inhibiting innate and adaptive immune responses. This review explores the characteristics and suppressive mechanisms of MDSCs, and discusses their potential applications as biomarkers and targets for clinical treatment of sepsis.

CYTOKINE & GROWTH FACTOR REVIEWS (2023)

Review Oncology

Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis

Hao Zhang et al.

Summary: Sepsis is a life-threatening condition characterized by dysfunction of the immune system and multiple organ failure due to exaggerated response to infection. Endothelial dysfunction is a hallmark of sepsis. Excessive neutrophil activation and release of neutrophil extracellular traps (NETs) contribute to endothelial cell pro-inflammatory and pro-coagulant phenotype, leading to compromised microcirculation, tissue hypoperfusion, and organ failure.

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Medical Laboratory Technology

Evaluation of the role of serum DcR3 levels in the early clinical prognosis of patients with Crimean-Congo hemorrhagic fever

Ferhan Kerget et al.

Summary: This study aimed to determine the relationship between early serum Decoy receptor-3 (DcR3) level and clinical severity in patients with Crimean-Congo hemorrhagic fever (CCHF). The results showed that symptoms such as fever, hemorrhage, nausea, headache, diarrhea, and hypoxia were significantly more common in severe CCHF patients. Serum DcR3 levels were higher in severe CCHF patients compared to mild/moderate patients and healthy individuals. Serum DcR3 may serve as a potential indicator for early immunomodulatory therapy in CCHF.

CLINICAL BIOCHEMISTRY (2023)

Review Medicine, General & Internal

2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department

Matteo Guarino et al.

Summary: This review aims to update physicians on the main pillars of treatment for sepsis/septic shock, which include empirical antimicrobial treatment, fluid replacement, and the use of vasoactive agents. Other treatments such as mechanical ventilation, anticoagulation, and glycemic control are also recommended but their efficacy is debated.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Hematology

Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity

Christina M. Termini et al.

Summary: The discovery of Syndecan-2 as a novel surface marker and regulator of hematopoietic stem cell (HSC) function has improved the understanding of HSC identity and their capacity for repopulation. Syndecan-2 expression is significantly increased in long-term HSCs compared to differentiated hematopoietic cells. Isolation of bone marrow cells based on Syndecan-2 expression results in a higher enrichment of HSCs with superior in vivo repopulating capacity, compared to conventional selection methods. Syndecan-2 regulates HSC repopulating capacity through control of Cdkn1c expression and HSC quiescence.
Review Infectious Diseases

Managing sepsis in the era of precision medicine: challenges and opportunities

Richard R. Watkins et al.

Summary: Precision medicine is a personalized medical model that tailors decisions and treatment plans based on predicted patient response or disease risk. This review highlights recent advances in the diagnosis and treatment of sepsis using precision medicine approaches, and discusses challenges and future research directions.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)

Article Urology & Nephrology

Sepsis Management for the Nephrologist

Sharad Patel et al.

Summary: The definition of sepsis has evolved significantly over the past three decades, now defined as a dysregulated host immune response to microbial invasion leading to end organ dysfunction. Early recognition and intervention remain key in sepsis management.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Review Public, Environmental & Occupational Health

Progress in Diagnosis and Treatment of Neonatal Sepsis: A Review Article

Pratibha Yadav et al.

Summary: Neonatal sepsis is a serious condition that can have harmful effects on the health of newborns. It is categorized into early onset and late onset based on the time of onset. Although the incidence of early-onset group B streptococcal infection has decreased, it remains a major cause of neonatal sepsis. Early diagnosis and prompt treatment still present a challenge.

JOURNAL OF NEPAL MEDICAL ASSOCIATION (2022)

Article Immunology

Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling

Shuo-Chun Weng et al.

Summary: DcR3 protects renal tubular epithelial cells from acute T-cell attack during T-cell priming by interfering with TNF ligand-mediated reverse signaling and promoting effector T-cell apoptosis. These findings support the role of decoy receptors in T-cell modulation in kidney transplant rejection.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

A LIGHT-HVEM/LTβR axis contributes to the fibrosis of intrauterine adhesion

Ayitila Abudukeyoumu et al.

Summary: This study found abnormal changes in the proportion of immune cell subsets in the endometrium of patients with IUA. The high expression of LIGHT on CD4(+) T cells and macrophages may contribute to the inflammation and fibrosis formation of IUA.

JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)

Review Immunology

Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review

Wang-Dong Xu et al.

Summary: TL1A, a member of tumor necrosis factor family, is expressed in various immune cells and involved in the development and pathogenesis of autoimmune diseases. This study comprehensively discusses the complex immunological function of TL1A and focuses on its pleiotropic activity in inflammatory autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Review Pharmacology & Pharmacy

Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis

Xu-Hua Wang et al.

Summary: This paper discusses the interaction between intestinal microbiota and sepsis, and explores the use of traditional Chinese medicine (TCM) in the treatment of sepsis.

FRONTIERS IN PHARMACOLOGY (2022)

Review Immunology

Dysregulation of neutrophil death in sepsis

Cheng-long Zhu et al.

Summary: Sepsis is a common disease with high mortality rates and long-term morbidity. Neutrophil cell death, including various types like necrosis, apoptosis, necroptosis, pyroptosis, NETosis, and autophagy, plays a crucial role in the development and progression of sepsis. However, the exact role and mechanisms of neutrophil cell death in sepsis still need further investigation.

FRONTIERS IN IMMUNOLOGY (2022)

Review Medicine, General & Internal

SEPSIS DEFINITION: WHAT'S NEW IN THE TREATMENT GUIDELINES

Ivana Srzic et al.

Summary: Sepsis is a life-threatening organ dysfunction caused by an unregulated response of a host. Septic shock is its most severe form. It is still one of the leading causes of mortality worldwide. Improving the definition of sepsis and developing guidelines for its treatment have led to better outcomes for patients. Timely diagnosis is crucial for the outcomes for patients with sepsis and septic shock.

ACTA CLINICA CROATICA (2022)

Review Medicine, General & Internal

Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options

Di Liu et al.

Summary: Sepsis is a common complication of combat injuries and trauma, characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection. Immunosuppression, one of the major causes of septic death, can be reversed and host resistance can be established by targeting it.

MILITARY MEDICAL RESEARCH (2022)

Review Immunology

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression

Ren-Qi Yao et al.

Summary: Sepsis-induced immune depression is a significant factor leading to severe infection and death. However, detecting the immune dysfunction caused by sepsis is challenging, highlighting the importance of specific biomarkers in clinical practice. Stratifying septic patients with an immunosuppressive state can contribute to personalized treatment.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation

Nan-Lin Wu et al.

Summary: DcR3 is regulated by EGFR in keratinocytes and involved in modulating the pattern of terminal differentiation. It interacts with PKC to enhance PKC activity. This study reveals the mechanism of how DcR3 regulates abnormal keratinocyte development in psoriasis.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

Review Gastroenterology & Hepatology

Postoperative sepsis after colorectal surgery: a prospective single-center observational study and review of the literature

Francesk Mulita et al.

Summary: The study identified that postoperative sepsis following colorectal surgery is significantly associated with patient age, ASA classification, diabetes, and cardiovascular disease.

GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2022)

Review Anesthesiology

Epidemiology of sepsis and septic shock

Catherine Chiu et al.

Summary: The epidemiology of sepsis and septic shock is challenging to study due to changing diagnostic definitions and a focus on high-income countries in research. Since 1991, the incidence of sepsis has continued to increase globally, with the latest definitions providing better mortality risk assessment. However, there are concerns that the true global burden of sepsis, including in low-income countries, may be underestimated.

CURRENT OPINION IN ANESTHESIOLOGY (2021)

Article Critical Care Medicine

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021

Laura Evans et al.

CRITICAL CARE MEDICINE (2021)

Article Immunology

Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology

Eleanor A. Fallon et al.

Summary: Research findings indicate that PD1(-/-) neonatal mice show improved survival rates in experimental sepsis, while PDL1(-/-) mice did not show significant improvement in survival. Focus on the impact of PD1 gene deficiency on lung injury reveals a potential regulatory role of the PD1/PDL1 pathway in the neonatal pulmonary immune response to septic insult. Investigation on human neonatal lung tissue also suggests the therapeutic potential of targeting PD1/PDL1 checkpoint proteins in septic neonates.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation via Reduction of Reactive Oxygen Species Production and Lysosomal Rupture

Yi-Gen Pan et al.

Summary: The study demonstrated that DcR3's HBD can reduce MSU crystal-induced NLRP3 inflammasome activation by regulating mitochondrial and lysosomal functions, suggesting a potential new therapeutic approach for gout.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC

Mengya Zhong et al.

Summary: The study revealed that both TIPE and DcR3 are highly expressed in colorectal cancer (CRC) patients with their levels showing a positive correlation. DcR3 was found to be highly expressed in the plasma of cancer patients. TIPE regulates the expression of DcR3 by activating the PI3K/AKT signaling pathway in CRC, promoting cell proliferation and migration while inhibiting apoptosis.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Emerging mechanisms of immunocoagulation in sepsis and septic shock

Daolin Tang et al.

Summary: Recent advances have shed light on the complex interplay between mammalian immunity and coagulation in sepsis, particularly involving inflammasomes and GSDMD-mediated pyroptosis, along with signaling pathways mediated by HMGB1, STING1, or SQSTM1. Pharmacological modulation of these pathways presents novel and promising therapeutic strategies for sepsis.

TRENDS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Divergent Sepsis Pathophysiology in Older Adults

Meagan S. Kingren et al.

Summary: The incidence and mortality rates of sepsis increase significantly with age, especially in older adults. However, there is currently a lack of effective therapeutic strategies targeting older patients with severe sepsis, despite ongoing research efforts. Further research using aged animal models with clinically relevant treatments is essential for future progress in this area.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Review Medicine, Research & Experimental

Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment

Toshiaki Iba et al.

Summary: The diagnostic criteria for overt DIC were established by ISTH in 2001, with recent research shedding light on the role of coagulation disorders in sepsis progression. The introduction of SIC as a pragmatic scoring system aims to detect early-stage sepsis-associated DIC, while globally agreed anticoagulant therapy for DIC is still lacking. International collaborative studies are deemed necessary for future advancements in diagnostic tools and treatment strategies.

ARCHIVES OF MEDICAL RESEARCH (2021)

Article Immunology

Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children

Asmaa Kamal et al.

Summary: Bronchial asthma is a common chronic inflammatory disease in children, and decoy receptor 3 (DcR3) may serve as a promising biomarker for pediatric asthma, especially in patients with allergic tendencies.

IMMUNOLOGIC RESEARCH (2021)

Article Critical Care Medicine

Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn Patients

Dong Min et al.

Summary: The study investigated the clinical value of DcR3 in severe burn patients, finding that higher DcR3 levels were associated with non-survival. DcR3 correlated well with PCT and appeared as a useful biomarker for monitoring severity and predicting mortality in severe burns. Cell experiments revealed that DcR3 increase could be influenced by specific stimulators and inhibitors in burn patients.

JOURNAL OF BURN CARE & RESEARCH (2021)

Review Immunology

Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis

Chuqiao Wang et al.

Summary: Sepsis, a systemic inflammatory disorder induced by infection, has high incidence and mortality rates, with survivors often facing long-term sequelae. Novel approaches are needed to address the challenges it presents. Long non-coding RNAs (lncRNAs) have been shown to play significant roles in sepsis, potentially serving as diagnostic markers and therapeutic targets. Further research is necessary to fully understand the molecular mechanisms and pathological processes underlying sepsis.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis

Christina Nedeva

Summary: Sepsis is a life-threatening medical condition caused by abnormal immune responses. It consists of two phases: immune activation and immunosuppression leading to immune cell death. Lack of specific treatments is mainly due to limited knowledge of the immuno-physiology associated with the disease.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Signaling pathways and intervention therapies in sepsis

Yun-yu Zhang et al.

Summary: Sepsis is a life-threatening organ dysfunction caused by dysregulated host systemic inflammatory and immune response to infection. Advanced understanding of host-microorganism interaction has led to new definitions and therapeutic approaches. Research focus has shifted from pathogenicity of microorganisms to the molecular basis of host responses.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Medicine, General & Internal

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis

Dimitrios Velissaris et al.

Summary: Sepsis is a severe condition with high mortality rate and an ideal biomarker remains unknown. Presepsin may be a valuable tool for assessing septic patients and plays an important role in the emergency department and intensive care unit. Further research is needed to evaluate the clinical implications of utilizing presepsin measurements in the workup of sepsis.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Kombucha ameliorates LPS-induced sepsis in a mouse model

Penghui Wang et al.

Summary: Kombucha, as a traditional fermented beverage, shows anti-inflammatory effects by improving survival rates and reducing inflammatory markers in sepsis-induced mice, while also positively impacting the gut microbiota.

FOOD & FUNCTION (2021)

Article Medical Laboratory Technology

Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations

P. Huang et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2020)

Review Medicine, Research & Experimental

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads

Jean-Marc Cavaillon et al.

EMBO MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

Molecular mechanisms of FasL-mediated 'reverse-signaling'

Subramaniam Malarkannan

MOLECULAR IMMUNOLOGY (2020)

Review Biochemical Research Methods

Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses

Andrew C. Liu et al.

BRIEFINGS IN BIOINFORMATICS (2020)

Article Critical Care Medicine

Biomarkers of sepsis: time for a reappraisal

Charalampos Pierrakos et al.

CRITICAL CARE (2020)

Article Medicine, General & Internal

Sepsis and septic shock: current approaches to management

Kelly Thompson et al.

INTERNAL MEDICINE JOURNAL (2019)

Review Surgery

Intra-abdominal sepsis: new definitions and current clinical standards

A. Hecker et al.

LANGENBECKS ARCHIVES OF SURGERY (2019)

Review Emergency Medicine

Sepsis: mechanisms of bacterial injury to the patient

Hayk Minasyan

SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE (2019)

Article Medicine, Research & Experimental

Decoy receptor-3 regulates inflammation and apoptosis via PI3K/AKT signaling pathway in coronary heart disease

Xinjing Chen et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)

Review Biology

Sepsis: evolving concepts and challenges

R. Salomao et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)

Article Obstetrics & Gynecology

Low plasma levels of decoy receptor 3 (DcR3) in the third trimester of pregnancy with preeclampsia

Chang-Ching Yeh et al.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2019)

Review Medicine, General & Internal

Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases

Shuo-Chun Weng et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)

Article Biotechnology & Applied Microbiology

Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure

Su Lin et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Review Cell Biology

Sepsis: Inflammation Is a Necessary Evil

Christina Nedeva et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

The Pathogenesis of Sepsis and Potential Therapeutic Targets

Min Huang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Pediatrics

Sepsis management and the pediatric surgeon

Laura A. Boomer et al.

SEMINARS IN PEDIATRIC SURGERY (2019)

Article Biochemistry & Molecular Biology

Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis

Jing-Jing Zhao et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)

Article Medical Laboratory Technology

Prognostic value of DcR3 in solid tumors: A meta-analysis

Hua Ge et al.

CLINICA CHIMICA ACTA (2018)

Article Medicine, General & Internal

Sepsis - thoughtful management for the non-expert

Robert Tidswell et al.

CLINICAL MEDICINE (2018)

Review Medicine, General & Internal

Sepsis and septic shock

Maurizio Cecconi et al.

LANCET (2018)

Article Medicine, Research & Experimental

Decoy receptor 3 alleviates hepatic fibrosis through suppressing inflammation activated by NF-κB signaling pathway

Zhenjing Jin et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-B signalling

Yanqiang Hou et al.

BMC BIOCHEMISTRY (2018)

Review Medicine, General & Internal

Sepsis as a model for improving diagnosis

Mark L. Graber et al.

DIAGNOSIS (2018)

Article Critical Care Medicine

Value of Serum Cholinesterase Activity in the Diagnosis of Septic Shock Due to Bacterial Infections

Mabrouk Bahloul et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2017)

Article Medicine, General & Internal

Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury

Tzu-Hao Li et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients

Ming-Han Chen et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)

Article Neurosciences

Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model

Yi-Ling Liu et al.

MOLECULAR NEURODEGENERATION (2017)

Editorial Material Medicine, General & Internal

Recognizing Sepsis as a Global Health Priority - A WHO Resolution

Konrad Reinhart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biotechnology & Applied Microbiology

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis

Chaojie Liang et al.

ONCOTARGETS AND THERAPY (2017)

Review Medicine, Research & Experimental

Sepsis: A Review of Advances in Management

Jordi Rello et al.

ADVANCES IN THERAPY (2017)

Review Immunology

The immunopathology of sepsis and potential therapeutic targets

Tom van der Poll et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Cell Biology

Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions

Shie-Liang Hsieh et al.

JOURNAL OF BIOMEDICAL SCIENCE (2017)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Genetics & Heredity

DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality

Ming-Ting Huang et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2015)